Literature DB >> 16642254

Activation of Salmonella-specific immune responses in the intestinal mucosa.

Aparna Srinivasan1, Stephen J McSorley.   

Abstract

The mammalian immune response to Salmonella has long been a subject of scientific study. Indeed, many of the general aspects of bacterial pathogenesis and host immune defense have been well described. However, a lack of clarity remains concerning important aspects of the host immune response to Salmonella, particularly with regard to the induction of an immune response in the intestinal mucosa. A major limitation has been the general lack of knowledge about specific antigenic targets that are recognized by both the innate and adaptive immune response in the intestine. Progress towards the identification of these targets is critical for the development of a detailed model of immunity to Salmonella and will lead to a better understanding of mucosal immune responses to other intracellular pathogens.

Entities:  

Mesh:

Year:  2006        PMID: 16642254     DOI: 10.1007/s00005-006-0003-5

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  11 in total

Review 1.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 2.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

3.  Salmonella pathogenicity island 1 differentially modulates bacterial entry to dendritic and non-phagocytic cells.

Authors:  Susan M Bueno; Aniela Wozniak; Eduardo D Leiva; Sebastián A Riquelme; Leandro J Carreño; Wolf-Dietrich Hardt; Claudia A Riedel; Alexis M Kalergis
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

Review 4.  Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda.

Authors:  A J Griffin; S J McSorley
Journal:  Mucosal Immunol       Date:  2011-02-09       Impact factor: 7.313

5.  B7-H1 (programmed cell death ligand 1) is required for the development of multifunctional Th1 cells and immunity to primary, but not secondary, Salmonella infection.

Authors:  Seung-Joo Lee; Hope O'Donnell; Stephen J McSorley
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

6.  Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.

Authors:  Huoying Shi; Shifeng Wang; Roy Curtiss
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

7.  Expression of Toll/IL-1R domain-containing adaptor protein (TIRAP) is detrimental to primary clearance of Salmonella and is not required for the generation of protective immunity.

Authors:  Stu Jerke; Aparna Srinivasan; Stephen J McSorley
Journal:  Immunol Lett       Date:  2007-12-05       Impact factor: 3.685

8.  Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost.

Authors:  Karina Ramirez; Alejandra V E Capozzo; Scott A Lloyd; Marcelo B Sztein; James P Nataro; Marcela F Pasetti
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

Review 9.  Tracking the dynamics of salmonella specific T cell responses.

Authors:  James J Moon; Stephen J McSorley
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

10.  Effect of the Salmonella pathogenicity island 2 type III secretion system on Salmonella survival in activated chicken macrophage-like HD11 cells.

Authors:  Amanda L S Wisner; Andrew A Potter; Wolfgang Köster
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.